More work is required to elucidate the molecular mechanism by which Fmo4 is over-expressed in CDDO-Im-treated iMycEμ tumor cells and by which Fmo4 might contribute to the catabolism of this compound. The gene discussed is FMO4; the disease is neoplasm.